Naphthalene derivatives: A new series of selective cyclooxygenase-2 inhibitors.
暂无分享,去创建一个
N. Godessart | J Feixas | J M Jiménez | N Godessart | C Puig | L Soca | M I Crespo | J. Jiménez | C. Puig | J. Feixas | M. I. Crespo | L. Soca
[1] J Feixas,et al. Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors. , 2000, Journal of medicinal chemistry.
[2] C. Bayly,et al. From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors , 1996 .
[3] S. Iacobelli,et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. , 1994, The Journal of pharmacology and experimental therapeutics.
[4] M. Dougados,et al. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. , 1999, Rheumatology.
[5] T. Baumruker,et al. Mast cell signalling: a patent review , 1999 .
[6] J. López-Belmonte,et al. Selective induction of cyclo‐oxygenase‐2 activity in the permanent human endothelial cell line HUV‐EC‐C: biochemical and pharmacological characterization , 1997, British journal of pharmacology.